MOTS-c Protocols

Important Disclaimer: The following information is for research and educational purposes only. This is not personalized medical advice. Any use of MOTS-c should only be considered under the direct supervision of qualified healthcare professionals in appropriate clinical research settings.

Current Protocol Information

Based on available evidence, standardized dosing protocols for MOTS-c are not well-established in the published literature. The compound is primarily being investigated in preclinical studies and early-phase clinical trials.

Clinical Trial Evidence

One active Phase 2 clinical trial (NCT07505745) is currently recruiting participants to evaluate MOTS-c for improving insulin sensitivity in adults with prediabetes and overweight/obesity. However, the specific dosing protocol for this trial is not publicly available in the evidence provided.

Preclinical Research Context

Most current research on MOTS-c consists of:

Laboratory studies examining its effects on metabolic signaling
Animal models investigating cardiac protection and anti-inflammatory effects
Observational studies measuring circulating MOTS-c levels in various disease states

Research Limitations

The evidence does not contain specific information about:

Standardized human dosing ranges
Administration routes (injection, oral, etc.)
Treatment duration protocols
Safety monitoring parameters
Contraindications or drug interactions

Current Status

MOTS-c remains an investigational compound with ongoing clinical research. Established therapeutic protocols have not yet been published in peer-reviewed literature based on the available evidence. Healthcare providers and researchers interested in MOTS-c should refer to current clinical trial protocols and work within appropriate institutional review board-approved research frameworks.

Anyone considering MOTS-c should consult with qualified healthcare professionals who can provide guidance based on the most current clinical evidence and individual medical circumstances.

MOTS-c

Member access required